Abstract
Antimalarial drug resistance is one of the various biological challenges putting malaria control strategies at risk1 in a time when the burden of malaria globally seems to be at a crossroads, with the situation no longer improving.2 Although there are currently no malaria parasites circulating in any corner of the world that could not be effectively treated with the existing registered antimalarials,1 the emergence and spread of resistance in parasites has, historically, been a problem in our fight against malaria.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
